Risk factors
Nurix Therapeutics (NRIX) risk factors
Item 1A of every Nurix Therapeutics, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors70 risks3 new3 dropped7 reworded
Nurix highlights new operational inexperience in clinical trials and manufacturing. The company faces expanding regulatory scrutiny over drug pricing and tariffs. Foreign exchange risks are added due to unhedged currencies.
Filed Jan 28, 2026 - FY2024 10-K risk factors70 risks
Nurix faces heavy cumulative losses with an accumulated deficit of $738.8 million and no product revenues to date.
Filed Jan 28, 2025